Skip to main content
. 2020 Jul 29:10.2217/nnm-2020-0247. doi: 10.2217/nnm-2020-0247

Figure 5. Nanoparticles-based therapy for coronaviruses via preventing viral entry.

Figure 5.

NP: Nanoparticle; SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2; RBD: Receptor-binding domain.